Carlos D. Flombaum

Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

Ephraim S. Casper, Mark R. Green, David P. Kelsen et al. · Investigational New Drugs · 1994 · 440 citations

Oncology, Phase Ii Trial, Pancreatic Cancer +5

Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Darren R. Feldman, Michael Baum, Michelle S. Ginsberg et al. · Journal of Clinical Oncology · 2009 · 298 citations · Full text

Long–Term Renal Outcomes after Cisplatin Treatment

Sheron Latcha, Edgar A. Jaimes, Sujata Patil et al. · Clinical Journal of the American Society of Nephrology · 2016 · 243 citations · Full text

Sequential Dose-Intensive Paclitaxel, Ifosfamide, Carboplatin, and Etoposide Salvage Therapy for Germ Cell Tumor Patients

Robert J. Motzer, Madhu Mazumdar, Joel Sheinfeld et al. · Journal of Clinical Oncology · 2000 · 192 citations

Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution

Ilya Glezerman, Mark G. Kris, V.A. Miller et al. · Clinical Nephrology · 2009 · 112 citations